ATE193886T1 - Glycerolipide verbindungen und ihre anwendung zum transport einer aktiven substanz in eine zielzelle - Google Patents
Glycerolipide verbindungen und ihre anwendung zum transport einer aktiven substanz in eine zielzelleInfo
- Publication number
- ATE193886T1 ATE193886T1 AT98908156T AT98908156T ATE193886T1 AT E193886 T1 ATE193886 T1 AT E193886T1 AT 98908156 T AT98908156 T AT 98908156T AT 98908156 T AT98908156 T AT 98908156T AT E193886 T1 ATE193886 T1 AT E193886T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- active substance
- transporting
- application
- target cell
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 4
- -1 GLYCEROLIPID COMPOUNDS Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000001890 transfection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9701475A FR2759367A1 (fr) | 1997-02-10 | 1997-02-10 | Glycerolipides cationiques et complexes de glycerolipides cationiques et de substances actives, notamment pour la transfection de cellules |
| FR9715805A FR2759382A1 (fr) | 1997-02-10 | 1997-12-12 | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
| PCT/FR1998/000250 WO1998034910A1 (fr) | 1997-02-10 | 1998-02-10 | Composes glycerolipidiques utiles pour le transfert d'une substance active dans une cellule cible |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE193886T1 true ATE193886T1 (de) | 2000-06-15 |
Family
ID=26233309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98908156T ATE193886T1 (de) | 1997-02-10 | 1998-02-10 | Glycerolipide verbindungen und ihre anwendung zum transport einer aktiven substanz in eine zielzelle |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6218370B1 (de) |
| EP (1) | EP0901463B1 (de) |
| JP (1) | JP2000510869A (de) |
| AT (1) | ATE193886T1 (de) |
| AU (1) | AU727204B2 (de) |
| CA (1) | CA2251999A1 (de) |
| DE (1) | DE69800178T2 (de) |
| DK (1) | DK0901463T3 (de) |
| ES (1) | ES2149043T3 (de) |
| FR (1) | FR2759382A1 (de) |
| GR (1) | GR3034317T3 (de) |
| PT (1) | PT901463E (de) |
| WO (1) | WO1998034910A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2759382A1 (fr) * | 1997-02-10 | 1998-08-14 | Transgene Sa | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
| US6849272B1 (en) * | 1999-04-21 | 2005-02-01 | Massachusetts Institute Of Technology | Endosomolytic agents and cell delivery systems |
| EP1052287A3 (de) * | 1999-05-10 | 2003-07-09 | Transgene S.A. | Komplex zur Übertragung von einem interessierenden anionischen Substanz auf einer Zelle |
| EP1052288A1 (de) * | 1999-05-10 | 2000-11-15 | Transgene S.A. | Komplex zur Ubertragung einer anionischen Substanz in einen Zell |
| AU2637500A (en) * | 1999-12-10 | 2001-06-18 | Genzyme Corporation | Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| US20030229037A1 (en) * | 2000-02-07 | 2003-12-11 | Ulrich Massing | Novel cationic amphiphiles |
| GB0106041D0 (en) * | 2001-03-12 | 2001-05-02 | Cancer Res Ventures Ltd | Lipids and liposomes |
| US20070111201A1 (en) * | 2001-04-30 | 2007-05-17 | Benjamin Doranz | Reverse transfection of cell arrays for structural and functional analyses of proteins |
| US20050261214A1 (en) * | 2001-05-15 | 2005-11-24 | Serge Braun | Complexes for transferring substances of interest into a cell |
| EP1513853A2 (de) * | 2002-05-24 | 2005-03-16 | Neopharm, Inc. | Cardiolipin- zusamensetzungen, verfahren zu deren herstellung und verwendung |
| EA200401565A1 (ru) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты) |
| US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
| CN1826410B (zh) | 2003-07-21 | 2011-10-26 | 特兰斯吉恩股份有限公司 | 具有改良的胞嘧啶脱氨酶活性的多肽 |
| WO2005039558A1 (en) * | 2003-10-24 | 2005-05-06 | Transgene S.A. | Targeted delivery of therapeutically active compounds |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| WO2005056752A2 (en) | 2003-10-24 | 2005-06-23 | Gencia Corporation | Methods and compositions for delivering polynucleotides |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| EP1743440B1 (de) * | 2004-08-05 | 2009-10-07 | LG Electronics, Inc. | Unterbrechung der benutzung des frequenzschichtkonvergenzverfahrens |
| GB0425556D0 (en) * | 2004-11-19 | 2004-12-22 | Glaxo Group Ltd | Novel compounds |
| JP5172188B2 (ja) * | 2007-03-28 | 2013-03-27 | 富士フイルム株式会社 | フッ素置換アルキル基を有するグリセリド化合物 |
| US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
| FR2921369B1 (fr) * | 2007-09-25 | 2014-07-11 | Pf Medicament | Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux. |
| US8470977B2 (en) | 2008-03-14 | 2013-06-25 | Transgene S.A. | Antibody against the CSF-1R |
| MX2011007494A (es) | 2009-01-13 | 2011-08-12 | Transgene Sa | Uso de una fraccion de la mitocondria de acidos nucleicos de saccharomyces cerevisiae para la estimulacion inmune. |
| US11826423B2 (en) | 2016-11-16 | 2023-11-28 | Immunomic Therapeutics, Inc. | Nucleic acids for treatment of allergies |
| US11203629B2 (en) | 2017-04-22 | 2021-12-21 | Immunomic Therapeutics, Inc. | LAMP constructs |
| CA3061950A1 (en) | 2017-05-02 | 2018-11-08 | Immunomic Therapeutics, Inc. | Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens |
| EP3793595A1 (de) | 2018-05-15 | 2021-03-24 | Immunomic Therapeutics, Inc. | Verbesserte lamp-konstrukte mit allergenen |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| JP2022551732A (ja) | 2019-10-18 | 2022-12-13 | イミュノミック セラピューティックス， インコーポレイテッド | がん抗原を含む改良ｌａｍｐ構築物 |
| CN114980920A (zh) | 2019-11-18 | 2022-08-30 | 詹森生物科技公司 | 基于突变体calr和jak2的疫苗及其用途 |
| WO2022009051A1 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | A method for determining responsiveness to prostate cancer treatment |
| WO2022009052A2 (en) | 2020-07-06 | 2022-01-13 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| US20230024133A1 (en) | 2020-07-06 | 2023-01-26 | Janssen Biotech, Inc. | Prostate Neoantigens And Their Uses |
| CA3247515A1 (en) | 2022-04-10 | 2023-10-19 | Immunomic Therapeutics, Inc. | Bicistronic lamp constructions comprising genes that enhance the immune response and methods of their use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2958076B2 (ja) * | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法 |
| US5334761A (en) * | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
| AU6045094A (en) * | 1993-02-19 | 1994-09-14 | Nippon Shinyaku Co. Ltd. | Drug composition containing nucleic acid copolymer |
| DE19521412A1 (de) | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| GB9512363D0 (en) * | 1995-06-17 | 1995-08-16 | Bass Plc | Liquid containers and method of manufacture thereof |
| FR2759382A1 (fr) * | 1997-02-10 | 1998-08-14 | Transgene Sa | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique |
-
1997
- 1997-12-12 FR FR9715805A patent/FR2759382A1/fr not_active Withdrawn
-
1998
- 1998-02-10 JP JP10533896A patent/JP2000510869A/ja not_active Ceased
- 1998-02-10 US US09/171,129 patent/US6218370B1/en not_active Expired - Fee Related
- 1998-02-10 PT PT98908156T patent/PT901463E/pt unknown
- 1998-02-10 AU AU66266/98A patent/AU727204B2/en not_active Ceased
- 1998-02-10 DE DE69800178T patent/DE69800178T2/de not_active Expired - Fee Related
- 1998-02-10 EP EP98908156A patent/EP0901463B1/de not_active Expired - Lifetime
- 1998-02-10 WO PCT/FR1998/000250 patent/WO1998034910A1/fr not_active Ceased
- 1998-02-10 CA CA002251999A patent/CA2251999A1/fr not_active Abandoned
- 1998-02-10 DK DK98908156T patent/DK0901463T3/da active
- 1998-02-10 AT AT98908156T patent/ATE193886T1/de not_active IP Right Cessation
- 1998-02-10 ES ES98908156T patent/ES2149043T3/es not_active Expired - Lifetime
-
2000
- 2000-08-31 GR GR20000402004T patent/GR3034317T3/el not_active IP Right Cessation
-
2001
- 2001-03-02 US US09/796,650 patent/US6743781B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2149043T3 (es) | 2000-10-16 |
| FR2759382A1 (fr) | 1998-08-14 |
| GR3034317T3 (en) | 2000-12-29 |
| AU6626698A (en) | 1998-08-26 |
| US6218370B1 (en) | 2001-04-17 |
| DK0901463T3 (da) | 2000-10-23 |
| US20010036927A1 (en) | 2001-11-01 |
| US6743781B2 (en) | 2004-06-01 |
| WO1998034910A1 (fr) | 1998-08-13 |
| JP2000510869A (ja) | 2000-08-22 |
| DE69800178D1 (de) | 2000-07-20 |
| EP0901463B1 (de) | 2000-06-14 |
| PT901463E (pt) | 2000-12-29 |
| EP0901463A1 (de) | 1999-03-17 |
| AU727204B2 (en) | 2000-12-07 |
| DE69800178T2 (de) | 2001-02-15 |
| CA2251999A1 (fr) | 1998-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69800178D1 (de) | Glycerolipide verbindungen und ihre anwendung zum transport einer aktiven substanz in eine zielzelle | |
| AP9701007A0 (en) | Substituted azetidin-2-ones for treatment of atherosclerosis. | |
| IS7170A (is) | Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra | |
| NZ290757A (en) | Delivery of nucleic acid into a cell | |
| DK0659174T3 (da) | Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler | |
| ATE120738T1 (de) | 2,4-diamino-pyrimidin-3-oxid-derivate und deren verwendung bei der behandlung und zur verhütung von haarfall. | |
| TR200100075T2 (tr) | 2-Kuinolon ihtiva eden farmasötik bileşimler | |
| ATE205484T1 (de) | Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren | |
| YU114487A (en) | Process for obtaining pharmaceuticaly active 1-substituted oxindole-3-carboxamide | |
| ATE318260T1 (de) | Stabilisatormischung | |
| DE69825626D1 (de) | Heterozyklische cytotoxische wirkstoffe | |
| WO2002007677A3 (en) | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder | |
| IL136911A0 (en) | Heterocyclic topoisomerase poisons | |
| ATE113030T1 (de) | Hydroxyalkancarbonsäure-derivate und deren verwendung. | |
| DE69903838D1 (de) | Phosphoepoxide, verfahren zu deren herstellung und ihre verwendungen | |
| ES8601861A1 (es) | Un metodo de obtener un isocianato bloqueado | |
| TR199902433T2 (xx) | Yeni piridin t�revleri ve bunlar� i�eren ispen�iyari bile�imler. | |
| BR9813923A (pt) | N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos | |
| EA200001107A1 (ru) | ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ | |
| ATE250594T1 (de) | Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen | |
| DE69830653D1 (en) | Chelatisierungsmitteln | |
| FR2501676B1 (de) | ||
| NO982260L (no) | Forbedret fremgangsmÕte for bestemmelse av lipase | |
| ES2105254T3 (es) | Derivados de penteno, su obtencion y empleo. | |
| DE3768469D1 (de) | N-substituierte, estergruppen enthaltende acrylamide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |